| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (methicillin-susceptible) |
0.12 |
8 |
? － ? |
Levofloxacin (Levaquin, Quixin)  |
36 |
| Staphylococcus aureus (methicillin-susceptible) |
>0.12 |
>256 |
0.12 － >256 |
Clindamycin (Cleocin) |
448 |
| Staphylococcus aureus (Methicillin-susceptible) |
0.125 |
0.125 |
0.03 － 0.25 |
Retapamulin |
596 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 0.125 |
Biapenem |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 0.125 |
Meropenem (Merrem) |
952 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.125 |
0.063 － 2 |
Moxifloxacin (BAY 12-8039, Avelox) |
19 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
0.032 － 8 |
R-95867 |
600 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
≥0.063 － 0.25 |
Faropenem |
56 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
0.25 |
0.063 － 4 |
Gatifloxacin (Tequin) |
109 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
1 |
0.06 － 2 |
Levofloxacin (Levaquin, Quixin) |
1601 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
1 |
0.125 － 32 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
8 |
≤0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococcus aureus (methicillin-susceptible) |
0.125 |
8 |
0.125 － 64 |
Levofloxacin (Levaquin, Quixin) |
1464 |
| Staphylococcus aureus (methicillin-susceptible) |
0.13 |
0.13 |
0.06 － 0.5 |
Daptomycin (Cubicin) |
7 |
| Staphylococcus aureus (methicillin-susceptible) |
0.2 |
0.2 |
0.1 － 0.39 |
Faropenem |
40 |
| Staphylococcus aureus (methicillin-susceptible) |
0.2 |
0.2 |
0.1 － 0.39 |
Levofloxacin (Levaquin, Quixin) |
17 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.03 － 0.5 |
TAK-599 |
162 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.06 － 0.25 |
Sparfloxacin (AT-4140, Zagam) |
374 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.06 － 0.5 |
Chloroeremomycin (LY264826, A-82846B) |
51 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.06 － 0.5 |
LY 191145 |
51 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.06 － 0.5 |
Telavancin (TD-6424, Vibativ) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 0.25 |
Levofloxacin (Levaquin, Quixin) |
175 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
73 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
186 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 1 |
Tigecycline (GAR-936, Tigacyl) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
≤0.12 － 2 |
Imipenem |
475 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － >16 |
Ertapenem (Invanz) |
55 |
| Staphylococcus aureus (methicillin-susceptible) |
0.25 |
0.25 |
0.12 － 16 |
Fusidic acid (Fucidin) |
604 |